Product Information
LEVETIRACETAM 750 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.1105 per EA under NDC 68001040407. Its NADAC has been published 337 times since Mar 11, 2020.
FDA first approved this application on Jan 15, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001040407
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078993FDA Approved
1/15/2009
TE Code
AB
On Market Since
6/19/2019
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 750 MG TABLET has been published 337 times since Mar 11, 2020, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.1804 (Jun 10, 2020) |
| All-time low | $0.0954 (Nov 20, 2024) |
| 52-week high | $0.1191 |
| 52-week low | $0.1105 |
| Median price | $0.1426 |
| Average price | $0.1425 |
| Largest weekly change | -24.3% (Nov 20, 2024) |
| Weeks tracked | 337 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 750 MG TABLET, manufactured by BluePoint Laboratories, is $0.1105 per EA (NDC 68001040407), effective Aug 19, 2026.
How has the price of LEVETIRACETAM 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 750 MG TABLET has declined 37.0%. It has been tracked across 337 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 750 MG TABLET?
Since Mar 11, 2020, the NADAC for LEVETIRACETAM 750 MG TABLET has ranged from a low of $0.0954 (Nov 20, 2024) to a high of $0.1804 (Jun 10, 2020), with a median of $0.1426 per EA.
Are there cheaper alternatives to LEVETIRACETAM 750 MG TABLET?
Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1056 per EA — about 4% below LEVETIRACETAM 750 MG TABLET.
Who manufactures LEVETIRACETAM 750 MG TABLET?
LEVETIRACETAM 750 MG TABLET (NDC 68001040407) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.